CRISPRINT Trademark

Trademark Overview


On Monday, August 9, 2021, a trademark application was filed for CRISPRINT with the United States Patent and Trademark Office. The USPTO has given the CRISPRINT trademark a serial number of 90873220. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Algen Biotechnologies, Inc.. The CRISPRINT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development in the field of drug discovery; scientific research and product development in the field of genetics and drug discovery; scientific research, namely, identification, isolation, functional analysis, sequencing and mapping of genes; research and development in the field of biotechnology and gene networking technology for use in therapeutic discovery and development; scientific research and technological research in the fields of gene discovery, gene network informatics, and drug discovery; providing temporary use of nondownloadable medical software for managing therapeutic discovery activities related to gene networking, namely, screening and prioritizing therapeutic agents for further evaluation and development, discovering novel biomarkers, validating biomarker strategies, gathering insights for patient selection and stratification for therapeutic treatment, and generating and storing therapeutic insights about the role a particular gene plays in a given diseas...
crisprint

General Information


Serial Number90873220
Word MarkCRISPRINT
Filing DateMonday, August 9, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements


Pseudo MarkCRISP PRINT
Goods and Servicesresearch and development in the field of drug discovery; scientific research and product development in the field of genetics and drug discovery; scientific research, namely, identification, isolation, functional analysis, sequencing and mapping of genes; research and development in the field of biotechnology and gene networking technology for use in therapeutic discovery and development; scientific research and technological research in the fields of gene discovery, gene network informatics, and drug discovery; providing temporary use of nondownloadable medical software for managing therapeutic discovery activities related to gene networking, namely, screening and prioritizing therapeutic agents for further evaluation and development, discovering novel biomarkers, validating biomarker strategies, gathering insights for patient selection and stratification for therapeutic treatment, and generating and storing therapeutic insights about the role a particular gene plays in a given disease and about the mechanism of action and therapeutic index of particular therapeutic agents

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlgen Biotechnologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107

Party NameAlgen Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107

Trademark Events


Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, November 6, 2023ASSIGNED TO EXAMINER
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 8, 2023SOU EXTENSION 1 FILED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 16, 2022NON-FINAL ACTION E-MAILED
Monday, May 16, 2022NON-FINAL ACTION WRITTEN
Sunday, May 8, 2022ASSIGNED TO EXAMINER
Friday, January 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 12, 2021NEW APPLICATION ENTERED